论文部分内容阅读
目的分析遵义市居民期望寿命,了解主要死因对遵义市居民期望寿命的影响,为制定疾病预防和控制策略提供科学依据。方法收集2014年遵义市死因监测点数据和漏报数据,运用简略寿命表和去死因简略寿命表,计算期望寿命、去死因期望寿命、寿命损失年数和损失率等指标。结果 2014年遵义市死因监测点居民期望寿命为75.76岁,男性和女性依次为73.41岁和78.43岁,女性期望寿命比男性高5.02岁。去除循环系统疾病、肿瘤、呼吸系统疾病、损伤与中毒、消化系统疾病前5位死因后,人均期望寿命可依次增加6.66、2.03、1.97、1.35和0.40岁,男性期望寿命增幅与全人群一致,女性期望寿命顺位与全人群略有差别,呼吸系统疾病居第2位。去除脑血管病、心脏病、恶性肿瘤和慢性下呼吸道疾病后,期望寿命分别增长2.80岁、2.31岁、0.92岁、0.87岁。结论遵义市居民期望寿命值有待进一步提高,重点应加强心脑血管疾病、恶性肿瘤以及慢性下呼吸道疾病等慢性非传染性疾病的防治工作。
Objective To analyze the life expectancy of residents in Zunyi, understand the impact of the main cause of death on the life expectancy of residents in Zunyi and provide a scientific basis for formulating disease prevention and control strategies. Methods The data of the death causes in Zunyi City in 2014 were collected and the omission data were collected. The life expectancy, life expectancy, loss of life expectancy and loss rate were calculated by using simple life table and simple life table of death cause. Results The life expectancy of residents in Zunyi City at the death monitoring point was 75.76 years old in 2014, followed by 73.41 years and 78.43 years for males and females and 5.02 years for males. After removing the top 5 causes of death from circulatory diseases, tumors, respiratory diseases, injuries and poisonings, and digestive diseases, the average life expectancy per capita could increase by 6.66, 2.03, 1.97, 1.35 and 0.40 years in sequence. The increase in male life expectancy was consistent with that in the general population, Female life expectancy rankings slightly different from the general population, respiratory diseases ranked No. 2. After removing cerebrovascular diseases, heart diseases, malignant tumors and chronic lower respiratory tract diseases, the expected life expectancy increased by 2.80 years, 2.31 years, 0.92 years and 0.87 years respectively. Conclusion The life expectancy of residents in Zunyi City needs to be further improved, and the prevention and treatment of chronic non-communicable diseases such as cardiovascular and cerebrovascular diseases, malignant tumors and chronic lower respiratory diseases should be emphasized.